PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12972984::ACT039559

MAVP

Evidence text

Paper-level observation

scratch wound healing assays (Fig. 1G) confirmed the inhibitory effects of MAVP on HUVEC migration, with dose-dependent reduction in wound closure rates (Fig. 1H).
textConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Cytotoxic
Measure
percent_inhibition
Comparator
=
Raw observation
dose-dependent reduction in wound closure rates
Normalized measurement
Not reported by source
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
HUVEC
Assay method
Not reported by source
Sequence
MAGGGATWLPPR
Standardization
ready simple

Source publication

Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia

Bioactive Materials · 2026

DOI 10.1016/j.bioactmat.2026.03.009 PMC12972984
Parent mention

Related peptide identities

PEPDIA-PLP-001965

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.